We are live on ! Find out more
CCA

Conestoga Capital Advisors Portfolio holdings

AUM $4.6B
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
+5.66%
1 Year Est. Return
+16.08%
3 Year Est. Return
+47.77%
5 Year Est. Return
+64.2%
10 Year Est. Return
+537.86%
AUM
$4.96B
AUM Growth
+$365M
Cap. Flow
+$188M
Cap. Flow %
3.8%
Top 10 Hldgs %
29.97%
Holding
148
New
2
Increased
84
Reduced
18
Closed
5

Top Buys

Rank Stock Value
1
RP
RealPage, Inc.
RP
+$36.8M
2
QTWO icon
Q2 Holdings
QTWO
+$30.3M
3
MRCY icon
Mercury Systems
MRCY
+$22.9M
4
CWST icon
Casella Waste Systems
CWST
+$20.6M
5
MODN
MODEL N, INC.
MODN
+$19.6M

Top Sells

Rank Stock Value
1
AIN icon
Albany International
AIN
+$50.3M
2
BLKB icon
Blackbaud
BLKB
+$40.7M
3
PRLB icon
Protolabs
PRLB
+$21.9M
4
TREX icon
Trex
TREX
+$19.4M
5
PCTY icon
Paylocity
PCTY
+$18.4M

Sector Composition

Rank Sector Weight
1 Technology 30.81%
2 Industrials 29.02%
3 Healthcare 18.03%
4 Consumer Discretionary 8.43%
5 Materials 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MKL icon
101
Markel Group
MKL
$23.2B
$826K 0.02%
849
– –
ALGN icon
102
Align Technology
ALGN
$12.3B
$721K 0.01%
2,202
– –
FTNT icon
103
Fortinet
FTNT
$117B
$720K 0.01%
30,565
– –
FDS icon
104
Factset
FDS
$10.2B
$700K 0.01%
2,091
– –
ABBV icon
105
AbbVie
ABBV
$435B
$695K 0.01%
7,935
– –
VEEV icon
106
Veeva Systems
VEEV
$37.4B
$689K 0.01%
2,450
– –
MMM icon
107
3M
MMM
$94.3B
$670K 0.01%
4,999
-239
-5% -$32.1K
LIN icon
108
Linde
LIN
$226B
$663K 0.01%
2,785
– –
ROP icon
109
Roper Technologies
ROP
$39.8B
$658K 0.01%
1,665
+280
+20% +$116K
PFE icon
110
Pfizer
PFE
$153B
$643K 0.01%
18,453
+421
+2% +$14.8K
XOM icon
111
ExxonMobil
XOM
$634B
$640K 0.01%
18,654
– –
KMB icon
112
Kimberly-Clark
KMB
$36.5B
$628K 0.01%
4,250
– –
JNJ icon
113
Johnson & Johnson
JNJ
$625B
$595K 0.01%
3,996
– –
INTU icon
114
Intuit
INTU
$89B
$589K 0.01%
1,805
– –
ADBE icon
115
Adobe
ADBE
$105B
$557K 0.01%
1,135
-115
-9% -$53.5K
MRK icon
116
Merck
MRK
$318B
$552K 0.01%
6,969
– –
PG icon
117
Procter & Gamble
PG
$339B
$548K 0.01%
3,940
– –
IDXX icon
118
Idexx Laboratories
IDXX
$46.2B
$541K 0.01%
1,375
– –
WCN
119
Waste Connections
WCN
$42B
$476K 0.01%
4,585
+1,035
+29% +$103K
SJM icon
120
J.M. Smucker
SJM
$12.8B
$474K 0.01%
4,105
– –
IPGP icon
121
IPG Photonics
IPGP
$3.84B
$472K 0.01%
2,775
– –
GRMN
122
Garmin
GRMN
$60B
$434K 0.01%
4,570
– –
DLB icon
123
Dolby
DLB
$5.79B
$422K 0.01%
6,368
– –
XYL icon
124
Xylem
XYL
$28.1B
$419K 0.01%
4,980
-900
-15% -$70.1K
MA icon
125
Mastercard
MA
$493B
$411K 0.01%
1,215
– –
2 3 4
5
6

Similar funds

SCM
Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
SCM
Shelton Capital Management Denver, Colorado $4.57B AUM 32.26% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $4.53B AUM 21.1% 1-Year Est. Return

Conestoga Capital Advisors's Q3 2020 Portfolio in Review

As of Q3 2020, Conestoga Capital Advisors held 148 positions worth $4.96B, up 7.9% from $4.59B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Conestoga Capital Advisors deployed $188M of net new capital in Q3 2020, opening 2 new positions and adding to 84 existing holdings. Its largest new stake was Laird Superfood: 50,000 shares worth $2.29M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 31% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Protolabs, an estimated $21.9M trimmed.

  • Conestoga Capital Advisors's largest Q3 2020 buy was Laird Superfood: 50,000 shares worth $2.29M.
  • Conestoga Capital Advisors added most to RealPage, Inc. in Q3 2020, an estimated $36.8M increase.
  • Conestoga Capital Advisors's biggest Q3 2020 reduction was Protolabs, cutting an estimated $21.9M.
  • Conestoga Capital Advisors fully exited Albany International in Q3 2020, selling an estimated $50.3M.
  • Conestoga Capital Advisors's ten largest holdings make up 30% of its $4.96B portfolio in Q3 2020.
  • Conestoga Capital Advisors opened 2 new positions and closed 5 in Q3 2020.
  • Conestoga Capital Advisors's portfolio value rose 7.9% quarter-over-quarter to $4.96B.

Based on Conestoga Capital Advisors's 13F filing for Q3 2020, filed 23 Oct 2020.